Related Experiment Video
Updated: Mar 22, 2026

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
Published on: January 8, 2020
Methods to control for unmeasured confounding in pharmacoepidemiology: an overview
Md Jamal Uddin1,2, Rolf H H Groenwold3, Mohammed Sanni Ali3
1Department of Statistics (Biostatistics and Epidemiology), Shahjalal University of Science and Technology, Sylhet, 3114, Bangladesh. jamal-sta@sust.edu.
This review overviews methods to address unmeasured confounding in pharmacoepidemiology. It highlights design-phase and data-analysis techniques, emphasizing combined statistical and clinical interpretation for accurate drug safety studies.
Area of Science:
- Pharmacoepidemiology
- Biostatistics
- Health Research Methods
Background:
- Unmeasured confounding poses significant challenges in pharmacoepidemiologic research.
- Various methods exist to address unmeasured confounding during study design or data analysis.
Purpose of the Study:
- To review common methods for detecting and controlling unmeasured confounding.
- To offer recommendations for their appropriate use in pharmacoepidemiology.
Main Methods:
- Design-phase methods include case-only designs (case-crossover, case-time control, self-controlled case series) and prior event rate ratio adjustment.
- Data-analysis methods encompass negative control, perturbation variable, instrumental variable, sensitivity analysis, and ecological analysis.
- Substudy-based approaches involve external adjustment, propensity score calibration, two-stage sampling, and multiple imputation.
Main Results:
- A comprehensive list of methods for managing unmeasured confounding is presented.
- These methods are categorized by their application in study design, data analysis, or through substudies.
- The review details specific techniques within each category, such as case-crossover and instrumental variable methods.
Conclusions:
- The effectiveness of methods for handling unmeasured confounding varies across studies and databases.
- Integrating statistical evidence with clinical knowledge is crucial for interpreting pharmacoepidemiologic study results accurately.
More Related Videos
08:21Author Spotlight: A Pharmacodissection Approach to Uncover Mechanisms in Cardiovascular Disease Risk Populations
Published on: July 21, 2023
08:36Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment
Published on: April 19, 2024
Related Concept Videos
Strategies for Assessing and Addressing Confounding
Confounding can be addressed at both the design phase of a study and through analytical methods after data...
Confounding in Epidemiological Studies
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Analysis of Population Pharmacokinetic Data
Pharmacokinetic–Pharmacodynamic Relationship: Problems
Dosage Regimens: Partial Pharmacokinetic Parameters